Article

Discovery of Potential Inhibitors of the Receptor-binding Domain (RBD) of Pandemic Disease-causing SARS-CoV-2 Spike Glycoprotein from Triphala Through Molecular Docking

2021-03-23

Abstract excerpt

Background: COVID-19 (SARS-CoV-2 infection) has affected almost every region of the world. Presently, there is no defined line of treatment available for it. Triphala is already proven to have a safe biological window, which is well known for its antioxidant and immunomodulatory properties. Objective: The present work has been carried out to study Triphala's effectiveness in the treatment of COVID-19. Methods: The...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 015d56c3-2f36-5cb7-8288-13c72bd04111
DOI: 10.2174/2666001601666210322121802

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Discovery of Potential Inhibitors of the Receptor-binding Domain (RBD) of Pandemic Disease-causing SARS-CoV-2 Spike Glycoprotein from Triphala Through Molecular DockingDOI 10.2174/2666001601666210322121802Read

Daucosterol and Beta-Sitosterol – the Future-Ready phytochemicals from Terminalia chebula to combat SARS-CoV-2Semantic proximity Read

Annual SZ® A Novel Formulation For COVID-19 Therapy Clinical Trial StudiesSemantic proximity Read

Inhibition potential of natural flavonoids against selected omicron (B.1.19) mutations in the spike receptor binding domain of SARS-CoV-2: a molecular modeling approach.Semantic proximity Read

In Silico Discovery and Evaluation of Inhibitors of the SARS-CoV-2 Spike Protein–HSPA8 Complex Towards Developing COVID-19 Therapeutic DrugsSemantic proximity Read

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19Semantic proximity Read

Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry PerspectiveSemantic proximity Read

Structure Based Drug Repurposing Through Targeting Nsp9 Replicase and Spike Proteins of SARS-CoV-2Semantic proximity Read

DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHESSemantic proximity Read

Structural and Functional Characterization of Medicinal Plants as Selective Antibodies towards Therapy of COVID-19 SymptomsSemantic proximity Read

COVID-19 Infection: Targeting Possibilities for Treatment.Semantic proximity Read

In Silico Study of Coumarins: Wedelolactone as a Potential Inhibitor of the Spike Protein of the SARS-CoV-2 VariantsSemantic proximity Read

In-silico analysis of potential interaction of drugs and the SARS-CoV-2 spike proteinSemantic proximity Read